EP Patent

EP3801732A4 — DRUG DELIVERY METHODS AND SYSTEMS

Assigned to Morningside Venture Investments Ltd · Expires 2022-04-27 · 4y expired

What this patent protects

Patent listed against donepezil-hydrochloride.

Drugs covered by this patent

donepezil-hydrochloride (DONEPEZIL HYDROCHLORIDE)

Patent Metadata

Patent number: EP3801732A4
Jurisdiction: EP
Classification: —
Expires: 2022-04-27
Drug substance claim: No
Drug product claim: No
Assignee: Morningside Venture Investments Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.